medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2015, Number 614

<< Back Next >>

Rev Med Cos Cen 2015; 72 (614)

Uveítis aguda anterior asociada al antígeno leucocitario humano B27: Aspectos clínicos y epidemiológicos

Ramírez AAK

Language: Spanish
References: 14
Page: 163-166
PDF size: 45.45 Kb.


ABSTRACT

The term acute anterior uveitis refers to the inflammatory process that take place primarily at the anterior chamber of the eye, characterized by a sudden onset and limited duration. Of all cases of episode of uveitis, most are cases of anterior uveitis, and HLAB27- associated acute anterior uveitis is the most common identifiable cause. This disease tipically presents as a male aged between twenty and forty years, with sudden unilateral ocular pain and redness that can be accompanied by hipopion, blurred vision, and photophobia. The average duration of symptoms is 4-6 weeks, with propensity to unilateral alternation recurrence and 65% of patients suffer ocular complications. HLA-B27 associated acute anterior uveitis may be associated with seronegative spondyloarthropathies, ankylosing spondylitis is the most commonly associated.


REFERENCES

  1. Braakenburg A, De valk H, Boer J, Rothova A. Human Leukocyte Antigen-B27-associated Uveitis: Long-term Follow-up and Gender Differences. Am J Ophthalmol. 2007; 145: 472-479.

  2. Careless D, Inman R. Acute Anterior Uveitis: Clinical and Experimental Aspects. Semin Arthritis Rheum. 1995; 24: 432-441.

  3. Chang J, McCluskey P, Wakefield D. Acute Anterior Uveitis and HLA-B27. Surv Ophthalmol. 2005; 50: 364-388.

  4. Linssen A, Meenken C. Outcomes of HLA-B27-Positive and HLA-B27- Negative Acute Anterior Uveitis. Am J Ophthalmol. 1995; 120: 351- 361.

  5. Loh A, Acharya N. Incidence Rates and Risk Factors for Ocular Complications and Vision Loss in HLA-B27-Associated Uveitis. Am J Ophthalmol 2010; 150: 534-542.

  6. Monnet D, Breban M, Hudry C, Dougados M, Brezin A. Ophtalmic Findigs and Frequency of Extraocular Manifestations in Patients with HLA-B27 Uveitis. Ophtalmology. 2004;111:802-809.

  7. Muñoz- Fernandez S, Martín-Mola E. Uveitis. Best Pract Res Clin Rheumatol. 2006;20: 487-505.

  8. Natkunarajah M, Kaptoge S, Edelsten C. Risks of relapse in patients with acute anterior uveitis. Br J Opthalmol.2007;91: 330-334.

  9. Power W, Rodriguez A, Pedroza- Seres M, Foster S. Outcomes in Anterior Uveitis Associated with the HLA-B27 Haplotype. Ophtalmology. 1998; 105:1646- 1651.

  10. Riordan-Eva P, Cunningham E. Vaughan and Asbury´s General Ophthalmology. 18 Ed. McGraw- Hill Companies, Inc ; 2011.

  11. Smith W. Gender and Spondyloarthropathy-Associated Uveitis. Journal of Ophthalmology. 2013; Article ID 928264, 6 pages.

  12. Suhler E, Martin T, Rosenbaum J. HLA-B27-associated uveitis: overview and current perspectives. Curr Opin Ophthalmol. 2003; 14:378–383.

  13. Tay-Kearney M, Schwam B, Lowder C, Dunn J, Meisler D, Vitale S, Jabs D. Clinical Features and Associated Systemic Disease of HLA-B27 Uveitis. Am J Ophthalmol. 1996; 121:47-56.

  14. The Standarization of Uveitis Nomenclature (SUN) Working Group. Standardization of Uveitis Nomenclature for Reporting Clinical Data: Results of the First International Workshop. Am J Ophthalmol. 2005;140: 509-516.




2020     |     www.medigraphic.com